Tumour immunology: Exploitation of the weapon of immune destruction for cancer therapy: Taking aim before firing

Current Opinion in Immunology

Volumn 17, Issue 2, 2005, Pages 159-162

  Offringa, Rienk ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; DENDRITIC CELL VACCINE;

CANCER; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELL TRANSFER; CHRONIC MYELOID LEUKEMIA; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; EX VIVO STUDY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MUCOSA CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; TUMOR CELL; TUMOR IMMUNOLOGY; VACCINATION; WEAPON;

EID: 14844283133     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.02.006     Document Type: Editorial

References (28)

1. M.A. Cheever, D.B. Thompson, J.P. Klarnet, and P.D. Greenberg Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells J Exp Med 163 1986 1100 1112
2. W.M. Kast, R. Offringa, P.J. Peters, A.C. Voordouw, R.H. Meloen, A.J. van der Eb, and C.J. Melief Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes Cell 59 1989 603 614
3. D.M. Burns, and D.H. Crawford Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease Blood Rev 18 2004 193 209
4. S. Gottschalk, H. Heslop, and C. Rooney Adoptive Immunotherapy for EBV-associated malignancies Leuk Lymphoma 46 2005 1 10
5. H.J. Kolb, C. Schmid, A.J. Barrett, and D.J. Schendel Graft-versus-leukemia reactions in allogeneic chimeras Blood 103 2004 767 776
6. S.A. Rosenberg, J.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat Med 10 2004 909 915
7. Nestle FO, Farkas A, Conrad C: Dendritic-cell-based therapeutic vaccination against cancer. Curr Opin Immunol 2005, 17:163-169.
8. Adema GJ, de Vries IJM, Punt CJA, Figdor CG: Migration of dendritic cell based cancer vaccines: in vivo veritas? Curr Opin Immunol 2005, 17:170-174.
9. Revaz V, Nardelli-Haefliger D: The importance of mucosal immunity in defense against epithelial cancers. Curr Opin Immunol 2005, 17:175-179.
10. R. Offringa, A. de Jong, R.E. Toes, S.H. van der Burg, and C.J. Melief Interplay between human papillomaviruses and dendritic cells Curr Top Microbiol Immunol 276 2003 215 240
11. Blankenstein T: The role of tumor stroma in the interaction between tumor and immune system. Curr Opin Immunol 2005, 17:180-186.
12. Overvijk WW: Breaking tolerance in cancer immunotherapy: time to ACT. Curr Opin Immunol 2005, 17:187-194.
13. Wrzesinski C, Restifo NP: Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy. Curr Opin Immunol 2005, 17:195-201.
14. G.Q. Phan, J.C. Yang, R.M. Sherry, P. Hwu, S.L. Topalian, D.J. Schwartzentruber, N.P. Restifo, L.R. Haworth, C.A. Seipp, and L.J. Freezer Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci USA 100 2003 8372 8377
15. J. Gong, D. Chen, M. Kashiwaba, Y. Li, L. Chen, H. Takeuchi, H. Qu, G.J. Rowse, S.J. Gendler, and D. Kufe Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells Proc Natl Acad Sci USA 95 1998 6279 6283
16. M.M. Soares, V. Mehta, and O.J. Finn Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection J Immunol 166 2001 6555 6563
17. J. Xia, Y. Tanaka, S. Koido, C. Liu, P. Mukherjee, S.J. Gendler, and J. Gong Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells J Immunol 170 2003 1980 1986
18. Y. Luo, D. O'Hagan, H. Zhou, M. Singh, J. Ulmer, R.A. Reisfeld, F. James Primus, and R. Xiang Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice Vaccine 21 2003 1938 1947
19. B. Singh, S. Read, C. Asseman, V. Malmstrom, C. Mottet, L.A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie Control of intestinal inflammation by regulatory T cells Immunol Rev 182 2001 190 200
20. V. Vezys, and L. Lefrancois Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen J Immunol 169 2002 6677 6680
21. + T cells pass through an effector phase during the process of in vivo tolerance induction J Immunol 170 2003 3945 3953
22. A.Y. Huang, P.H. Gulden, A.S. Woods, M.C. Thomas, C.D. Tong, W. Wang, V.H. Engelhard, G. Pasternack, R. Cotter, and D. Hunt The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product Proc Natl Acad Sci USA 93 1996 9730 9735
23. S. Malarkannan, T. Serwold, V. Nguyen, L.A. Sherman, and N. Shastri The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma Proc Natl Acad Sci USA 93 1996 13991 13996
24. T. van Hall, N.E. van de Rhee, S.P. Schoenberger, M.P. Vierboom, F.A. Verreck, C.J. Melief, and R. Offringa Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes Cancer Res 58 1998 3087 3093
25. J.C. Yang, and D. Perry-Lalley The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors J Immunother 23 2000 177 183
26. Hambach L, Goulmy E: Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 2005, 17:202-210.
27. H.G. Ljunggren, and K. Karre In search of the 'missing self': MHC molecules and NK cell recognition Immunol Today 11 1990 237 244
28. Ruggeri L, Mancusi A, Capanni M, Martelli MF, Velardi A: Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr Opin Immunol 2005, 17:211-217.